Conditions: Hypercholesterolemia
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 146
Healthy volunteers: no

Brief summary:
Evaluate the safety of the long-term (1 year) coadministration of ezetimibe and atorvastatin in participants with hypercholesterolemia who have not reached low density lipoprotein (LDL)-cholesterol target with 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors.

Detailed description:

Arms:
arm 1: Ezetimibe 10 mg + Atorvastatin 20 mg

Interventions: intervention 1: Ezetimibe intervention 2: atorvastatin
Intervention descriptions: intervention 1: Ezetimibe 10 mg once daily intervention 2: atorvastatin 20 mg once daily

Protocol document: